dr. P.C. Jutte

E-mail:
p.c.jutte umcg.nl

Research

Research interests

Paul Jutte (MD PhD) is orthopaedic surgeon since 2004. He completed a fellowship in orthopedic oncology in Bologna (Italy) (2003)  and Los Angeles (USA) (2005). His PhD was on spinal tuberculosis (2006). His present position is head of the department of orthopaedic surgery (A/Prof) at University Medical Center Groningen, The Netherlands. He founded a regional clinical network for orthopedic infections and holds several chair positions. His current work is aimed at minimizing tissue damage, improving safety and efficacy of surgical treatment of tumor and infection. He published over 150 peer reviewed papers (H-factor 26) and is co-program leader of MBM (Man Biomaterials Microbes), a research line at W.J. Kolff institute at the University of Groningen, The Netherlands.

 

 

Publications
  1. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study

    TGCT Study Group, Mastboom, M. J. L., Palmerini, E., Verspoor, F. G. M., Rueten-Budde, A. J., Stacchiotti, S., Staals, E. L., Schaap, G. R., Jutte, P. C., Aston, W., Gelderblom, H., Leithner, A., Dammerer, D., Takeuchi, A., Thio, Q., Niu, X., Wunder, J. S. & van de Sande, M. A. J., Jun-2019, In : Lancet Oncology. 20, 6, p. 877-886 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers

    Tenosynovial Giant Cell Tumors (TGCT) Study Group, Mastboom, M. J. L., Staals, E. L., Verspoor, F. G. M., Rueten-Budde, A. J., Stacchiotti, S., Palmerini, E., Schaap, G. R., Jutte, P. C., Aston, W., Leithner, A., Dammerer, D., Takeuchi, A., Thio, Q., Niu, X., Wunder, J. S. & van de Sande, M. A. J., 17-Jul-2019, In : Journal of Bone and Joint Surgery: American Volume. 101, 14, p. 1309-1318 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Debridement, antibiotics and implant retention is a viable treatment option for early periprosthetic joint infection presenting more than four weeks after index arthroplasty

    Northern Infection Network Joint Arthroplasty (NINJA) and ESCMID study group for implant-associated infections (ESGIAI), Löwik, C. A. M., Parvizi, J., Jutte, P. C., Zijlstra, W. P., Knobben, B. A. S., Xu, C., Goswami, K., Belden, K. A., Sousa, R., Carvalho, A., Martínez-Pastor, J. C., Soriano, A. & Wouthuyzen-Bakker, M., 1-Nov-2019, In : Clinical Infectious Diseases. 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Accepting higher morbidity in exchange for sacrificing fewer animals in studies developing novel infection-control strategies

    Busscher, H. J., Woudstra, W., van Kooten, T. G., Jutte, P., Shi, L., Liu, J., Hinrichs, W. L. J., Frijlink, H. W., Shi, R., Liu, J., Parvizi, J., Kates, S., Rotello, V. M., Schaer, T. P., Williams, D., Grainger, D. W. & van der Mei, H. C., Feb-2020, In : Biomaterials. 232, 8 p., 119737.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (110) »

ID: 468152